— Know what they know.
Not Investment Advice

MRZM OTC

Marizyme, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +29900.0% 3Y: -99.7% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $39538 mcap · 86M float · 0.0021% daily turnover · Short 100% of daily vol

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2025-08-27
Earliest Filing
2025-08-27
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named MRZM in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
AIXC Qualigen Therapeutics, Inc. supplier Borrower under the Amended and Restated Secured Demand Promissory Note 2025-08-27 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms